Monster Stocks Hold Next: 3 Long-Term Winners to Own
Ready for a portfolio that ages well with time? This guide zeroes in on three monster stocks hold next—MercadoLibre, ...
When Is An Index Fund Priced
Index funds are priced at the end of the trading day based on net asset value and intraday adjustments. This intro explains the timing and what to watch.
15,016 articlesFreshworks Executive Sold Over: Is FRSH Stock a Buy?
An insider stake moved when a Freshworks executive sold over 32,577 shares for roughly $275,000. This article breaks ...
Two Recession-Resistant Dividend Stocks to Buy Now
In uncertain times, one reliable approach is to target recession-resistant dividend stocks. This article shines a lig...
Oracle's AI-Fueled Growth Silences Doubters — for Now
Oracle has faced skepticism around AI spending and cloud growth. This article digs into how Oracle's AI-Fueled Growth...
Exclusive: Accounting Startup Cryptio Raises $45M Series B
Cryptio has closed a $45 million Series B to scale its enterprise crypto accounting platform, aiming to help large fi...
Where Could Tesla Years Lead by 2028? A Base Case View
This article lays out a grounded three-year path for Tesla, focusing on core EV leadership, software-based autonomy r...
Joint (JYNT) 2025 Earnings: Q4 Review and Outlook
A fresh, no-copy analysis of Joint (JYNT) 2025 earnings, focusing on Q4 results, margin trends, and the roadmap for 2...
Lucid Versus Rivian: Which EV Stock Will Survive This Year?
Rivian unveils the R2 with a sub-$45k price target and near-term shipments, while Lucid battles cash burn and no 2026...
Home Equity Decreases Nationally as 2025 Ends, Market Signals
A late-2025 market study shows home equity decreases nationally in Q4, signaling a cool-down after a sizzling run for...
XRP Keeps Stalling $1.45: Price Faces Major Hurdle
XRP remains trapped around $1.45, facing a tough resistance zone between $1.76 and $1.80. On-chain data shows a large...
I've Changed Mind Microsoft: Why My Stock View Has Shifted
I’ve shifted my stance on MSFT stock as the AI era deepens, driven by Azure momentum, productivity platforms, and str...
Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status